| Age, mean (SD) [range] |
34.5 (8.85) [20–54] |
| Parity n (percentage) |
|
| - Nulliparous |
38 (52.8) |
| - Parous |
34 (47.2) |
| - Previous CS |
13 (18.1) |
| Hormone treatment n (percentage) |
|
| - Nil |
30 (41.7) |
| - Combined Oral Contraceptive Pill |
10 (13.9) |
| - Progesterone Only Pill |
2 (2.8) |
| - DepoProvera™
|
2 (2.8) |
| - Levonogesterol releasing intrauterine system |
11 (15.3) |
| - GnRH analogue |
2 (2.8) |
| - Oophorectomy with add back Hormone replacement therapy |
2 (2.8) |
| Laparoscopic findings n (percentage) |
|
| - No visible pathology |
26 (37.1) |
| - Endometriosis |
32 (45.7) |
| Stage I |
12 (37.5) |
| Stage II |
7 (21.9) |
| Stage III |
3 (9.4) |
| Stage IV |
8 (25.0) |
| Stage not documented |
2 |
| - Adhesions |
7 (10.0) |
| - Dermoid cysts |
5 (7.1) |
| Total number of operations: mean (SD) [range] |
1.9 (1.1) [0–5] |
| Pain medication n (percentage) |
|
| - Analgesics (8 not documented) |
57 (90.5) |
| - Neuroleptics |
23 (32.9) |
| Global pain score /100: mean (SD) [range] |
31.9 (26.3) [0–87] |
| Duration of symptoms in months: mean (SD) [Range] |
92 (94) [6–456] |
